Kevin W. Bock

6.4k total citations
36 papers, 1.0k citations indexed

About

Kevin W. Bock is a scholar working on Epidemiology, Molecular Biology and Artificial Intelligence. According to data from OpenAlex, Kevin W. Bock has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Molecular Biology and 7 papers in Artificial Intelligence. Recurrent topics in Kevin W. Bock's work include Influenza Virus Research Studies (6 papers), Internet Traffic Analysis and Secure E-voting (6 papers) and Network Security and Intrusion Detection (5 papers). Kevin W. Bock is often cited by papers focused on Influenza Virus Research Studies (6 papers), Internet Traffic Analysis and Secure E-voting (6 papers) and Network Security and Intrusion Detection (5 papers). Kevin W. Bock collaborates with scholars based in United States, United Kingdom and Italy. Kevin W. Bock's co-authors include Ian N. Moore, David Twell, David Honys, John M. Ward, Senthilkumar Padmanaban, Heven Sze, Kendal D. Hirschi, Dave Levin, Elaine W. Lamirande and Kanta Subbarao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Immunology.

In The Last Decade

Kevin W. Bock

35 papers receiving 1.0k citations

Peers

Countries citing papers authored by Kevin W. Bock

Since Specialization

Citations

This map shows the geographic impact of Kevin W. Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin W. Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin W. Bock more than expected).

Fields of papers citing papers by Kevin W. Bock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin W. Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin W. Bock. The network helps show where Kevin W. Bock may publish in the future.

Co-authorship network of co-authors of Kevin W. Bock

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin W. Bock. A scholar is included among the top collaborators of Kevin W. Bock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin W. Bock. Kevin W. Bock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies 2023 ·Nature Communications ·(unknown), John R. Gallagher, Alexander Kim, (unknown), (unknown), (unknown), Kevin W. Bock, Udana Torian, Ian N. Moore, Audray K. Harris	15
2	SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy 2023 ·Vaccine ·Yongjun Sui, Hanné Andersen, (unknown), (unknown), (unknown), Bianca M. Nagata, Kevin W. Bock, Derron A. Alves, Mark G. Lewis, Jay A. Berzofsky	1
3	Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus 2022 ·Frontiers in Immunology ·(unknown), John R. Gallagher, (unknown), (unknown), (unknown), Kevin W. Bock, Seyhan Boyoglu-Barnum, (unknown), Adrian Creanga, Derron A. Alves, Masaru Kanekiyo, Audray K. Harris	7
4	Weaponizing Middleboxes for {TCP} Reflected Amplification 2021 ·USENIX Security Symposium ·Kevin W. Bock, (unknown), (unknown), (unknown), Eric Wustrow, Dave Levin	3
5	Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor 2021 ·Nature Communications ·Chunfu Yang, Lei Lei, (unknown), Michael Briones, Li Ma, Gail L. Sturdevant, Hua Su, Anuj Kashyap, David W. Dorward, Kevin W. Bock, Ian N. Moore, (unknown), Chih‐Yu Chen, Craig Martens, Stacy Ricklefs, Masahiro Yamamoto, Kiyoshi Takeda, Yoichiro Iwakura, Grant McClarty, Harlan D. Caldwell	38
6	Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis 2020 ·PLoS Pathogens ·Michael D. Lewis, Andrea Paun, Audrey Romano, (unknown), (unknown), Ian N. Moore, Kevin W. Bock, Amanda Fortes Francisco, Jason M. Brenchley, David L. Sacks	17
7	Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans 2020 ·PLoS Pathogens ·Zhaochun Chen, Ronald E. Engle, Chen‐Hsiang Shen, Huaying Zhao, Peter Schuck, Emily J. Danoff, Hanh Nguyen, Norihisa Nishimura, Kevin W. Bock, Ian N. Moore, Peter D. Kwong, Robert H. Purcell, Sugantha Govindarajan, Patrizia Farci	4
8	Detecting and Evading Censorship-in-Depth: A Case Study of Iran’s Protocol Whitelister 2020 ·USENIX Security Symposium ·Kevin W. Bock, (unknown), (unknown), (unknown), Dave Levin	7
9	Geneva 2019 ·Kevin W. Bock, (unknown), (unknown), Dave Levin	28
10	A primate model of severe malarial anaemia: a comparative pathogenesis study 2019 ·Scientific Reports ·(unknown), Elizabeth B. Brickley, Jessica Taaffe, (unknown), Zhen Zhao, Kevin W. Bock, Sachy Orr-Gonzalez, Marvin L. Thomas, Lynn Lambert, Ian N. Moore, Patrick E. Duffy	3
11	Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma 2018 ·Molecular Cancer Research ·Giacomo Diaz, Ronald E. Engle, Ashley Tice, Marta Melis, (unknown), Jaime Rodriguez‐Canales, Jeffrey C. Hanson, Michael R. Emmert‐Buck, Kevin W. Bock, Ian N. Moore, Fausto Zamboni, Sugantha Govindarajan, David E. Kleiner, Patrizia Farci	44
12	Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 2018 ·Proceedings of the National Academy of Sciences ·Zhaochun Chen, Giacomo Diaz, Teresa Pollicino, Huaying Zhao, Ronald E. Engle, Peter Schuck, Chen‐Hsiang Shen, Fausto Zamboni, Zhifeng Long, Juraj Kabát, (unknown), Kevin W. Bock, Ian N. Moore, Kurt Wollenberg, Cinque Soto, Sugantha Govindarajan, Peter D. Kwong, David E. Kleiner, Robert H. Purcell, Patrizia Farci	57
13	King of the Hill: A Novel Cybersecurity Competition for Teaching Penetration Testing. 2018 ·USENIX Security Symposium ·Kevin W. Bock, (unknown), Dave Levin	16
14	A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques 2018 ·Scientific Reports ·Adam S. Cockrell, Joshua C. Johnson, Ian N. Moore, David X. Liu, Kevin W. Bock, Madeline G. Douglas, Rachel L. Graham, Jeffrey Solomon, (unknown), (unknown), Randy Hart, Ralph S. Baric, Reed F. Johnson	15
15	Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model 2017 ·Scientific Reports ·Norinne Lacerda‐Queiroz, Nicolas Riteau, Richard T. Eastman, Kevin W. Bock, Marlene S. Orandle, Ian N. Moore, Alan Sher, Carole A. Long, Dragana Janković, Xin‐zhuan Su	23
16	Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines 2017 ·npj Vaccines ·Troy C. Sutton, Saborni Chakraborty, Vamsee Mallajosyula, Elaine W. Lamirande, Ketaki Ganti, Kevin W. Bock, Ian N. Moore, Raghavan Varadarajan, Kanta Subbarao	39
17	In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice 2017 ·Journal of Virology ·Troy C. Sutton, Elaine W. Lamirande, Kevin W. Bock, Ian N. Moore, Wouter Koudstaal, (unknown), Gerrit Jan Weverling, Jaap Goudsmit, Kanta Subbarao	38
18	Acidic chitinase primes the protective immune response to gastrointestinal nematodes 2016 ·Nature Immunology ·Kevin M. Vannella, Thirumalai R. Ramalingam, Kevin M. Hart, (unknown), Joshua Sciurba, Luke Barron, Lee A. Borthwick, Allen Smith, Margaret Mentink‐Kane, Sandra White, Robert W. Thompson, Allen W. Cheever, Kevin W. Bock, Ian N. Moore, Lori Fitz, Joseph F. Urban, Thomas A. Wynn	45
19	Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection 2016 ·The Journal of Infectious Diseases ·Katherine V. Houser, (unknown), Tianlei Ying, Yanping Wang, Leatrice Vogel, Elaine W. Lamirande, Kevin W. Bock, Ian N. Moore, Dimiter S. Dimitrov, Kanta Subbarao	71
20	Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis 2015 ·The Journal of Infectious Diseases ·André Kübler, Christer Larsson, Brian Luna, Bruno B. Andrade, Eduardo P. Amaral, Michael E. Urbanowski, Marlene S. Orandle, Kevin W. Bock, Nicole C. Ammerman, Laurene S. Cheung, Kathryn Winglee, Marc K. Halushka, Jin Kyun Park, Alan Sher, Jon S. Friedland, Paul Elkington, William R. Bishai	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact